Three new lignan glycosides, akeqintoside A [(7
S,8
S)-7,8-dihydro-8-hydroxymethyl-7-(4-hydroxy-3-methoxyphenyl)-1′-benzofuranpropanol 2′-
O-β-
D-glucopyranoside] (
1), akeqintoside B [(7
R,8
R)-7,8-dihydro-8-hydroxymethyl-7-(4-hydroxy-3-methoxyphenyl)-1′-(9′-methoxy-7′-propenyl) benzofuran 2′-
O-β-
D-glucopyranoside] (
2), and akequintoside C [7
R*,8
R*-dihydroxy-7-(4-hydroxy-3-methoxyphenyl)-glycerol 9-
O-β-
D-(6′-
O-caffeoyl)-glucopyranoside] (
3) were isolated from
Akebia quinata along with five known compounds, syringin (
4), vanilloloside (
5), salidroside (
6), 3,4-dihydroxyphenylethyl alcohol 8-
O-β-
D-glucopyranoside (
7), and calceolarioside B (
8). The structures of the compounds were identified based on one dimensional (1D)- and 2D-NMR, including
1H–
1H correlation spectroscopy (COSY), heteronuclear single quantum coherence (HSQC), heteronuclear multiple bond connectivity (HMBC) and nuclear Overhauser effect spectroscopy (NOESY) spectroscopic analyses. The inhibitory activity of these isolated compounds against interleukin-6 (IL-6) production in tumor necrosis factor-alpha (TNF-α) stimulated MG-63 cells was also examined.
View full abstract